Virax Biolabs VRAX
NASDAQ VRAX
$1.34 -0.03 (-2.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Operating Leases (2023 - 2026)

Updated

Virax Biolabs (VRAX) posted Operating Leases of $304,808 for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 4.5% from $291,543 a year earlier.

Analysis

Virax Biolabs (VRAX) Operating Leases (2023 - 2026) Analysis & Trends

Since fiscal Q2 2024, Virax Biolabs has reported Operating Leases for 6 quarters.

  • In prior fiscal years, Virax Biolabs' Operating Leases was $291,543 in FY2025 (+65.3%) and $176,345 in FY2024.
  • The fiscal Q4 2026 figure stands as the highest quarterly Operating Leases since fiscal Q2 2025.
  • On a year-over-year basis, Operating Leases increased in three of the last four quarters, with growth averaging 51.1%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Virax Biolabs 536,746.51 -20.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 304,808.00
Sep 30, 2025 276,043.00
Mar 31, 2025 291,543.00
Sep 30, 2024 332,098.00
Mar 31, 2024 176,345.00
Sep 30, 2023 132,027.00
API Access

Virax Biolabs Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=VRAX&period=max&api_key=YOUR_API_KEY